Relmada Therapeutics
RLMD
RLMD
86 hedge funds and large institutions have $44.9M invested in Relmada Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 40 reducing their positions, and 14 closing their positions.
Holders
86
Holders Change
-8
Holders Change %
-8.51%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
40
Closed
14
Calls
$140K
Puts
$914K
Net Calls
-$774K
Net Calls Change
+$359K
Top Buyers
Top Sellers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$14.9K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$1.3M |
| 3 |
3
Goldman Sachs
New York
|
$39K |
| 4 |
4
Two Sigma Investments
New York
|
$592K |
| 5 |
5
Millennium Management
New York
|
$733K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
101
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
102
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|